| Symbol |
Name |
|
A4GNT
|
alpha-1,4-N-acetylglucosaminyltransferase
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ACADVL
|
acyl-CoA dehydrogenase, very long chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACOX1
|
acyl-CoA oxidase 1, palmitoyl
|
|
ACPP
|
acid phosphatase, prostate
|
|
ACTB
|
actin, beta
|
|
ACVR1
|
activin A receptor, type I
|
|
ADAM15
|
ADAM metallopeptidase domain 15
|
|
ADAMTS12
|
ADAM metallopeptidase with thrombospondin type 1 motif, 12
|
|
AFP
|
alpha-fetoprotein
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AIRE
|
autoimmune regulator
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
AMBN
|
ameloblastin (enamel matrix protein)
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
|
ANTXR1
|
anthrax toxin receptor 1
|
|
ANXA1
|
annexin A1
|
|
ANXA7
|
annexin A7
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
AR
|
androgen receptor
|
|
ARHGEF4
|
Rho guanine nucleotide exchange factor (GEF) 4
|
|
ARID4A
|
AT rich interactive domain 4A (RBP1-like)
|
|
ARL6IP5
|
ADP-ribosylation factor-like 6 interacting protein 5
|
|
ASIP
|
agouti signaling protein
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATAD5
|
ATPase family, AAA domain containing 5
|
|
ATF2
|
activating transcription factor 2
|
|
ATF3
|
activating transcription factor 3
|
|
ATG4C
|
autophagy related 4C, cysteine peptidase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP11C
|
ATPase, class VI, type 11C
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
B3GNT6
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BECN1
|
beclin 1, autophagy related
|
|
BHLHA15
|
basic helix-loop-helix family, member a15
|
|
BHMT
|
betaine--homocysteine S-methyltransferase
|
|
BIN3
|
bridging integrator 3
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BLNK
|
B-cell linker
|
|
BMF
|
Bcl2 modifying factor
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BTG3
|
BTG family, member 3
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
BUB3
|
BUB3 mitotic checkpoint protein
|
|
CABLES1
|
Cdk5 and Abl enzyme substrate 1
|
|
CACFD1
|
calcium channel flower domain containing 1
|
|
CASC1
|
cancer susceptibility candidate 1
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBX7
|
chromobox homolog 7
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
|
CCM2L
|
cerebral cavernous malformation 2-like
|
|
CCNDBP1
|
cyclin D-type binding-protein 1
|
|
CCNG1
|
cyclin G1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD226
|
CD226 molecule
|
|
CD248
|
CD248 molecule, endosialin
|
|
CD34
|
CD34 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDC25A
|
cell division cycle 25A
|
|
CDK11A
|
cyclin-dependent kinase 11A
|
|
CDK5RAP2
|
CDK5 regulatory subunit associated protein 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CERS2
|
ceramide synthase 2
|
|
CHD2
|
chromodomain helicase DNA binding protein 2
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHORDC1
|
cysteine and histidine-rich domain (CHORD) containing 1
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
COPS6
|
COP9 signalosome subunit 6
|
|
CREBBP
|
CREB binding protein
|
|
CST3
|
cystatin C
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSG
|
cathepsin G
|
|
CUL9
|
cullin 9
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYGB
|
cytoglobin
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYTIP
|
cytohesin 1 interacting protein
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCLRE1A
|
DNA cross-link repair 1A
|
|
DDB2
|
damage-specific DNA binding protein 2, 48kDa
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEK
|
DEK proto-oncogene
|
|
DGKD
|
diacylglycerol kinase, delta 130kDa
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DMTF1
|
cyclin D binding myb-like transcription factor 1
|
|
DNA2
|
DNA replication helicase/nuclease 2
|
|
DND1
|
DND microRNA-mediated repression inhibitor 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DOK2
|
docking protein 2, 56kDa
|
|
DOK3
|
docking protein 3
|
|
DOT1L
|
DOT1-like histone H3K79 methyltransferase
|
|
DPH1
|
diphthamide biosynthesis 1
|
|
DRD2
|
dopamine receptor D2
|
|
E2F1
|
E2F transcription factor 1
|
|
EAF2
|
ELL associated factor 2
|
|
EEF1E1
|
eukaryotic translation elongation factor 1 epsilon 1
|
|
EGR1
|
early growth response 1
|
|
EIF2S2
|
eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa
|
|
ENTPD5
|
ectonucleoside triphosphate diphosphohydrolase 5
|
|
EPHA2
|
EPH receptor A2
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERCC8
|
excision repair cross-complementation group 8
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESAM
|
endothelial cell adhesion molecule
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV6
|
ets variant 6
|
|
EXO1
|
exonuclease 1
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase)
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FANCM
|
Fanconi anemia, complementation group M
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBLN5
|
fibulin 5
|
|
FBXO4
|
F-box protein 4
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF22
|
fibroblast growth factor 22
|
|
FHIT
|
fragile histidine triad
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLCN
|
folliculin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXM1
|
forkhead box M1
|
|
FOXN1
|
forkhead box N1
|
|
FOXO3
|
forkhead box O3
|
|
FPR2
|
formyl peptide receptor 2
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase)
|
|
FZR1
|
fizzy/cell division cycle 20 related 1 (Drosophila)
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GAST
|
gastrin
|
|
GLIPR1
|
GLI pathogenesis-related 1
|
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
|
|
GNMT
|
glycine N-methyltransferase
|
|
GON4L
|
gon-4-like (C. elegans)
|
|
GPR68
|
G protein-coupled receptor 68
|
|
GPRC5A
|
G protein-coupled receptor, class C, group 5, member A
|
|
GPX7
|
glutathione peroxidase 7
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H2AFX
|
H2A histone family, member X
|
|
HACE1
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HCST
|
hematopoietic cell signal transducer
|
|
HELQ
|
helicase, POLQ-like
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HINT1
|
histidine triad nucleotide binding protein 1
|
|
HIPK1
|
homeodomain interacting protein kinase 1
|
|
HIVEP3
|
human immunodeficiency virus type I enhancer binding protein 3
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGN1
|
high mobility group nucleosome binding domain 1
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HR
|
hair growth associated
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HTATIP2
|
HIV-1 Tat interactive protein 2, 30kDa
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IER3
|
immediate early response 3
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IGHM
|
immunoglobulin heavy constant mu
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL22
|
interleukin 22
|
|
IL22RA2
|
interleukin 22 receptor, alpha 2
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL5
|
interleukin 5
|
|
IL5RA
|
interleukin 5 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
ING1
|
inhibitor of growth family, member 1
|
|
ING2
|
inhibitor of growth family, member 2
|
|
INHA
|
inhibin, alpha
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
IP6K2
|
inositol hexakisphosphate kinase 2
|
|
IQGAP2
|
IQ motif containing GTPase activating protein 2
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF8
|
interferon regulatory factor 8
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
JAM3
|
junctional adhesion molecule 3
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF10
|
Kruppel-like factor 10
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT10
|
keratin 10, type I
|
|
KRT14
|
keratin 14, type I
|
|
KRT9
|
keratin 9, type I
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LIG1
|
ligase I, DNA, ATP-dependent
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LMO7
|
LIM domain 7
|
|
LRIG2
|
leucine-rich repeats and immunoglobulin-like domains 2
|
|
LTBP4
|
latent transforming growth factor beta binding protein 4
|
|
LYST
|
lysosomal trafficking regulator
|
|
LZTS1
|
leucine zipper, putative tumor suppressor 1
|
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAP3K6
|
mitogen-activated protein kinase kinase kinase 6
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM4
|
minichromosome maintenance complex component 4
|
|
MCM8
|
minichromosome maintenance complex component 8
|
|
MCM9
|
minichromosome maintenance complex component 9
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR122
|
microRNA 122
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP19
|
matrix metallopeptidase 19
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOS
|
v-mos Moloney murine sarcoma viral oncogene homolog
|
|
MPG
|
N-methylpurine-DNA glycosylase
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSH6
|
mutS homolog 6
|
|
MSI2
|
musashi RNA-binding protein 2
|
|
MSMB
|
microseminoprotein, beta-
|
|
MTF1
|
metal-regulatory transcription factor 1
|
|
MTSS1
|
metastasis suppressor 1
|
|
MTUS1
|
microtubule associated tumor suppressor 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUS81
|
MUS81 structure-specific endonuclease subunit
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
|
MZF1
|
myeloid zinc finger 1
|
|
NBN
|
nibrin
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA5
|
nuclear receptor coactivator 5
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NEIL1
|
nei endonuclease VIII-like 1 (E. coli)
|
|
NEU3
|
sialidase 3 (membrane sialidase)
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NIT1
|
nitrilase 1
|
|
NKX2-8
|
NK2 homeobox 8
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLRP12
|
NLR family, pyrin domain containing 12
|
|
NLRP6
|
NLR family, pyrin domain containing 6
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NRP1
|
neuropilin 1
|
|
NUAK2
|
NUAK family, SNF1-like kinase, 2
|
|
NUDT1
|
nudix (nucleoside diphosphate linked moiety X)-type motif 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
PAQR3
|
progestin and adipoQ receptor family member III
|
|
PAX6
|
paired box 6
|
|
PCSK6
|
proprotein convertase subtilisin/kexin type 6
|
|
PCYT1B
|
phosphate cytidylyltransferase 1, choline, beta
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PER2
|
period circadian clock 2
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PINX1
|
PIN2/TERF1 interacting, telomerase inhibitor 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLCL1
|
phospholipase C-like 1
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLG
|
plasminogen
|
|
PLK1
|
polo-like kinase 1
|
|
PLK3
|
polo-like kinase 3
|
|
PML
|
promyelocytic leukemia
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
POLD1
|
polymerase (DNA directed), delta 1, catalytic subunit
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POMC
|
proopiomelanocortin
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)
|
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta)
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTPRT
|
protein tyrosine phosphatase, receptor type, T
|
|
PVR
|
poliovirus receptor
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAE1
|
ribonucleic acid export 1
|
|
RALGAPA2
|
Ral GTPase activating protein, alpha subunit 2 (catalytic)
|
|
RALGDS
|
ral guanine nucleotide dissociation stimulator
|
|
RASAL2
|
RAS protein activator like 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RC3H1
|
ring finger and CCCH-type domains 1
|
|
RECQL4
|
RecQ protein-like 4
|
|
RET
|
ret proto-oncogene
|
|
RFWD2
|
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
|
|
RGPD1
|
RANBP2-like and GRIP domain containing 1
|
|
RHOB
|
ras homolog family member B
|
|
RINT1
|
RAD50 interactor 1
|
|
RNF19B
|
ring finger protein 19B
|
|
RNF8
|
ring finger protein 8, E3 ubiquitin protein ligase
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SAMD9L
|
sterile alpha motif domain containing 9-like
|
|
SAV1
|
salvador family WW domain containing protein 1
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SELL
|
selectin L
|
|
SF1
|
splicing factor 1
|
|
SFN
|
stratifin
|
|
SGOL1
|
shugoshin-like 1 (S. pombe)
|
|
SIPA1
|
signal-induced proliferation-associated 1
|
|
SIRT2
|
sirtuin 2
|
|
SKI
|
SKI proto-oncogene
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SLC29A3
|
solute carrier family 29 (equilibrative nucleoside transporter), member 3
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD9
|
SMAD family member 9
|
|
SMAP1
|
small ArfGAP 1
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMG1
|
SMG1 phosphatidylinositol 3-kinase-related kinase
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPN
|
sialophorin
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1
|
|
SRPX
|
sushi-repeat containing protein, X-linked
|
|
SSBP2
|
single-stranded DNA binding protein 2
|
|
STAB2
|
stabilin 2
|
|
STAG1
|
stromal antigen 1
|
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK11
|
serine/threonine kinase 11
|
|
STK3
|
serine/threonine kinase 3
|
|
STK4
|
serine/threonine kinase 4
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
SUV39H2
|
suppressor of variegation 3-9 homolog 2 (Drosophila)
|
|
TCF3
|
transcription factor 3
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TES
|
testin LIM domain protein
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFF1
|
trefoil factor 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
THBS2
|
thrombospondin 2
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TMPRSS11D
|
transmembrane protease, serine 11D
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNK1
|
tyrosine kinase, non-receptor, 1
|
|
TNXB
|
tenascin XB
|
|
TOM1L2
|
target of myb1-like 2 (chicken)
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TP53INP1
|
tumor protein p53 inducible nuclear protein 1
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TREX2
|
three prime repair exonuclease 2
|
|
TRIM24
|
tripartite motif containing 24
|
|
TRIM27
|
tripartite motif containing 27
|
|
TRIM62
|
tripartite motif containing 62
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSPAN33
|
tetraspanin 33
|
|
TTC7A
|
tetratricopeptide repeat domain 7A
|
|
TUSC2
|
tumor suppressor candidate 2
|
|
TXNIP
|
thioredoxin interacting protein
|
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats
|
|
UIMC1
|
ubiquitin interaction motif containing 1
|
|
UNG
|
uracil-DNA glycosylase
|
|
USP44
|
ubiquitin specific peptidase 44
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZFHX3
|
zinc finger homeobox 3
|